Recent hypertension trials: Implications and controversies
- 15 March 2005
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 45 (6), 813-827
- https://doi.org/10.1016/j.jacc.2004.10.069
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery DiseaseNew England Journal of Medicine, 2004
- ACE Inhibitors for Patients with Vascular Disease without Left Ventricular Dysfunction — May They Rest in PEACE?New England Journal of Medicine, 2004
- Cardiovascular Therapies and Risk for Development of DiabetesJournal of the American College of Cardiology, 2004
- Optimal low-density lipoprotein is 50 to 70 mg/dlJournal of the American College of Cardiology, 2004
- Adverse Prognostic Significance of New Diabetes in Treated Hypertensive SubjectsHypertension, 2004
- Atrial Fibrillation in HypertensionHypertension, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Calcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid AtherosclerosisCirculation, 2002
- Selected major risk factors and global and regional burden of diseaseThe Lancet, 2002
- Comparative Effects of Ramipril on Ambulatory and Office Blood PressuresHypertension, 2001